Possible indomethacin-aminoglycoside interaction in preterm infants.
D000583:Amikacin / Q000378:metabolism; D000617:Aminoglycosides / Q000097:blood / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000097:blood / Q000378:metabolism*; D003404:Creatinine / Q000097:blood; D004231:Diuresis / Q000187:drug effects; D004347:Drug Interactions; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy / Q000378:metabolism; D004573:Electrolytes / Q000097:blood; D005839:Gentamicins / Q000378:metabolism; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000378:metabolism; D011446:Prospective Studies
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004573:Electrolytes; D005839:Gentamicins; D000583:Amikacin; D003404:Creatinine; D007213:Indomethacin